Massachusetts General Hospital: Atrial Fibrillation trials
The registry lists 14 Atrial Fibrillation studies with Massachusetts General Hospital as lead sponsor. 4 are open to participants now and 3 have results posted.
Phase 1 1Phase 3 2Phase 4 1No phase 10(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Atrial Fibrillation Risk Estimation With Single-lead Handheld ElectrocardiogramsEnrolling by invitationNCT07468123Not applicable
- Safety and Effectiveness of Pulmonary Vein isOLation And posterioR Wall Ablation wIth pulSed Field Energy in Patients With Paroxysmal and Persistent AFRecruitingNCT06099730Not applicable
- Pragmatic Amiodarone Trial to Reduce Postoperative Atrial Fibrillation in Patients Undergoing Cardiac SurgeryNot yet recruitingNCT05543278Phase 4
- Positron Emission Tomography (PET) Imaging of ThrombosisRecruitingNCT03830320Phase 1
- Rivaroxaban vs. Warfarin for Post Cardiac Surgery Atrial FibrillationCompletedNCT03702582Phase 3Results posted
- Esophageal Deviation in Atrial Fibrillation AblationCompletedNCT03261973Not applicableResults posted
- OFDI Capsule Imaging in Patients With Atrial Fibrillation Undergone Radio Frequency (RF) AblationCompletedNCT02204566Not applicableResults posted
- Precision Medicine in Ischemic Stroke and Atrial FibrillationCompletedNCT04637087Not applicable
- Feasibility and Safety of Same Day Discharge afTer Atrial Fibrillation AblationWithdrawnNCT04199702Not applicable
- Screening for Atrial Fibrillation Among Older Patients in Primary Care ClinicsStatus unknownNCT03515057Not applicable
- SMART Program for Paroxysmal Atrial FibrillationCompletedNCT03450993Not applicable
- Automated Physician Notifications to Improve Guideline-Based Anticoagulation in Atrial FibrillationCompletedNCT02950285Not applicable
- Impact of the Relaxation Response Resiliency Program on Patients With Atrial FibrillationCompletedNCT02634697Not applicable
- Boston Area Anticoagulation Trial for Atrial Fibrillation (BAATAF)CompletedNCT00000517Phase 3